Go to the Link and you will get more information on many different Clinical Trials. These Trials are crucial. Without them, we cant move forward. CLINICAL TRIALS CANCER Seattle Cancer Center The knowledge we gain from clinical trials helps us develop more effective, less toxic cancer treatments. Each month we publish this newsletter with our Hotlist of the newest clinical trials that might be of interest to you and your patients. In this issue: SCCA Trial Leads to FDA Approval of Idelalisib for CLL Trastuzumab Plus Trimodal Treatment for Esophageal Cancer (RTOG-1010) Brentuximab Vedotin, Ifosfamide, Carboplatin, Etoposide for Relapsed or Refractory Hodgkin’s Lymphoma Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin’s Lymphoma Expanded Access of MK-3475 for Melanoma Enzalutamide for Castrate-Resistant Prostate Cancer SCCA Trial Leads to FDA Approval of Idelalisib for CLL Ajay K. Gopal, MD, and John M. Pagel, MD, PhD, were principal investigators of pivotal trials conducted at Seattle Cancer Care Alliance (SCCA) that led to last month’s U.S seattlecca.org/newsletters/clinical-trials-monthly-sep-2014.cfm#esophageal
Posted on: Sun, 14 Sep 2014 00:47:49 +0000
Trending Topics
Recently Viewed Topics
© 2015